{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:34:26Z","timestamp":1790080466091,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"publisher","award":["VZ-MDS-PI-0262"],"award-info":[{"award-number":["VZ-MDS-PI-0262"]}],"id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.leukres.2015.06.007","type":"journal-article","created":{"date-parts":[[2015,6,27]],"date-time":"2015-06-27T21:23:41Z","timestamp":1435440221000},"page":"957-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Azacitidine improves the T-cell repertoire in patients with myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia"],"prefix":"10.1016","volume":"39","author":[{"given":"Claudio","family":"Fozza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Corda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Barraqueddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Virdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Contini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Galleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Isoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Longinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2015.06.007_bib0200","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.06.007_bib0205","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/rheumatology\/keh136","article-title":"Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study","volume":"43","author":"Giannouli","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.leukres.2015.06.007_bib0210","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2007-01-067546","article-title":"CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)","volume":"110","author":"Kordasti","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.06.007_bib0215","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000339498","article-title":"Patients with early-stage myelodysplastic syndromes show increased frequency of CD4+CD25+CD127(low) regulatory T cells","volume":"128","author":"Fozza","year":"2012","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0220","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0145-2126(91)90028-R","article-title":"The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: an in vitro study","volume":"15","author":"Smith","year":"1991","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2015.06.007_bib0225","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/icb.2010.139","article-title":"Bias in the \u03b1\u03b2 T-cell repertoire: implications for disease pathogenesis and vaccination","volume":"89","author":"Miles","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V98.1.165","article-title":"Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations","volume":"98","author":"Langerak","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.06.007_bib0235","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.4049\/jimmunol.152.10.5109","article-title":"Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status","volume":"152","author":"Gorski","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0240","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.exphem.2009.04.009","article-title":"Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset","volume":"37","author":"Fozza","year":"2009","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0245","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","article-title":"Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study","volume":"10","author":"Fenaux","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0250","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.leukres.2012.03.026","article-title":"Azacitidine differentially affects CD4(pos) T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes","volume":"36","author":"Bontkes","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2015.06.007_bib0255","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3324\/haematol.2012.074823","article-title":"The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome","volume":"98","author":"Costantini","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2015.06.007_bib0260","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1038\/bcj.2014.14","article-title":"5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies","volume":"4","author":"Gang","year":"2014","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2015.06.007_bib0265","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.leukres.2010.01.018","article-title":"Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines","volume":"34","author":"Santini","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2015.06.007_bib0270","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.06.007_bib0275","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate\u2013phenol\u2013chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.leukres.2015.06.007_bib0280","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1182\/blood-2004-04-1405","article-title":"Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients","volume":"105","author":"Chen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.06.007_bib0285","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1182\/blood-2003-11-3959","article-title":"Analysis of T-cell repertoire in hepatitis-associated aplastic anemia","volume":"103","author":"Lu","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.06.007_bib0290","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0609.2012.01762.x","article-title":"Are T-cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes?","volume":"88","author":"Fozza","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0295","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.leukres.2012.11.007","article-title":"The role of T-cells in the pathogenesis of myelodysplastic syndromes: passengers and drivers","volume":"37","author":"Fozza","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2015.06.007_bib0300","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2141.2003.04136.x","article-title":"A pilot study of antithymocyte globulin (ATG) in the treatment of patients with \u2018low-risk\u2019 myelodysplasia","volume":"120","author":"Killick","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0305","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1200\/JCO.2010.31.2686","article-title":"Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care \u2013 SAKK 33\/99","volume":"29","author":"Passweg","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0310","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1046\/j.1365-2141.1998.00920.x","article-title":"Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles","volume":"102","author":"Molldrem","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0315","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0925-5710(97)00042-X","article-title":"Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients","volume":"66","author":"Okamoto","year":"1997","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0320","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2141.1986.tb07504.x","article-title":"Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies","volume":"63","author":"Mufti","year":"1986","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0325","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of myeloid malignancies in patients with autoimmune conditions","volume":"100","author":"Anderson","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.leukres.2015.06.007_bib0330","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/leu.2008.333","article-title":"Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS)","volume":"23","author":"Kotsianidis","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2015.06.007_bib0335","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1182\/blood-2006-07-035519","article-title":"Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors","volume":"109","author":"Epling-Burnette","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.06.007_bib0340","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07593.x","article-title":"IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome","volume":"145","author":"Kordasti","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0345","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0609.2011.01708.x","article-title":"Patients with myelodysplastic syndromes show reduced frequencies of CD4(+) CD8(+) double-positive T cells","volume":"88","author":"Fozza","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0350","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0145-2126(01)00083-2","article-title":"Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process","volume":"25","author":"Epperson","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2015.06.007_bib0355","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.leu.2404590","article-title":"Prevalence and clinical association of clonal T-cell expansions in myelodysplastic syndrome","volume":"21","author":"Epling-Burnette","year":"2007","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2015.06.007_bib0360","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ejh.12417","article-title":"Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma","volume":"94","author":"Fozza","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0365","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.critrevonc.2012.11.005","article-title":"T-cell receptor repertoire usage in hematologic malignancies","volume":"86","author":"Fozza","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.leukres.2015.06.007_bib0370","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1596\/neo.11646","article-title":"CD4(+) and CD8(+) T-Cell skewness in classic Kaposi sarcoma","volume":"14","author":"Galleu","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.leukres.2015.06.007_bib0375","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood-2004-05-2017","article-title":"Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome","volume":"106","author":"Sloand","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.06.007_bib0380","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood-2010-04-277921","article-title":"T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy","volume":"117","author":"Sloand","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.06.007_bib0385","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1182\/blood-2009-11-249474","article-title":"Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia","volume":"116","author":"Goodyear","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.06.007_bib0390","doi-asserted-by":"crossref","first-page":"587","DOI":"10.18632\/oncotarget.1782","article-title":"Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615303337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615303337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T16:59:56Z","timestamp":1691773196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212615303337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0145212615303337"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2015.06.007","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azacitidine improves the T-cell repertoire in patients with myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2015.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}